ORHub, Inc. (ORHB)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT
-99.42%
Market Cap 171.11K
Revenue (ttm) 137.50K
Net Income (ttm) -17.65M
Shares Out 855.56M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25,000
Average Volume 5,983
Open 0.0002
Previous Close 0.0002
Day's Range 0.0002 - 0.0002
52-Week Range 0.0001 - 0.0385
Beta -1.48
RSI 59.50
Earnings Date n/a

About ORHub

ORHub, Inc. provides surgical software focusing on real-time surgical data analytics. The company's suite of products serves the needs of the health care industry, hospitals, patients, the government, and medical device vendors. The company provides a cloud-based software solution that captures information before, during, and after surgery. Its software applications allow hospitals and medical device vendors to utilize Web-enabled device to create an anatomical graphic depiction during surgery. The company is based in Phoenix, Arizona. [Read more]

Sector Healthcare
CEO Christopher Wiggins
Country United States
Stock Exchange OTCMKTS
Ticker Symbol ORHB
Full Company Profile

Financial Performance

Financial Statements

News

Hippofi Welcomes Scott Bauccio as New Head of Sales for Pur Biologics

IRVINE, CA / ACCESSWIRE / January 23, 2024 / HippoFi's (OTC PINK:ORHB) biotechnology business PUR Biologics, proudly announces Scott Bauccio as its new Head of Sales. Utilizing his 20 years of sales m...

1 year ago - Accesswire

HippoFi Ships International Orders and Expects Sales to Exceed $20 Million in the New Year

HippoFi's wholly owned subsidiary, PUR Biologics breaks into the international market. IRVINE, CA / ACCESSWIRE / December 11, 2023 / HippoFi's (OTC PINK:ORHB) biotechnology business PUR Biologics, beg...

1 year ago - Accesswire

HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities

Expanding our reach in 2024, HippoFi and PUR Biologics are setting new standards in innovative spine care solutions . IRVINE, CA / ACCESSWIRE / December 5, 2023 / (OTC PINK:ORHB) HippoFi's wholly owne...

1 year ago - Accesswire

Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization

Scientist, inventor, business expert, and holder of more than 140 patents will bring forward PUR Biologics' regenerative therapeutic patent portfolio to address unmet needs in the $200 billion osteoar...

1 year ago - Accesswire

International Sales Win for PUR Biologics

PUR Biologics' robust distribution channels prove to expand sales globally. IRVINE, CA / ACCESSWIRE / October 24, 2023 / Following a successful engagement at the North American Spine Society (NASS) co...

1 year ago - Accesswire

PUR Biologics Secures Innovative Medical Patent with Strong Financial Upside

IRVINE, CA / ACCESSWIRE / September 12, 2023 / Solidifying its role as a leader in medical advancements, PUR Biologics, a wholly-owned subsidiary of HippoFi (OTC PINK:ORHB), proudly announces its late...

1 year ago - Accesswire

HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation

IRVINE, CA / ACCESSWIRE / September 6, 2023 / HippoFi, Inc. (OTC PINK:ORHB) proudly announces a partnership with global medical technology leader ZIMMER BIOMET, aiming to redefine the spinal biologics...

1 year ago - Accesswire

HippoFi To Announce Strategic Alliance With Orthopedic Industry Leader

IRVINE, CA / ACCESSWIRE / September 1, 2023 / HippoFi, Inc. (OTC PINK:ORHB) - HippoFi, in association with its wholly owned subsidiary PUR Biologics, is preparing to unveil the details of the closing ...

1 year ago - Accesswire

US Patent Office Issues New Patent to PUR Biologics for Advanced Cartilage Regeneration and Arthritis Solutions

IRVINE, CA / ACCESSWIRE / August 14, 2023 / PUR Biologics, a wholly owned subsidiary of HippoFi (OTCPK:ORHB), proudly announces its newly granted patent, marking a significant advancement in addressin...

1 year ago - Accesswire

HippoFi Finalizes an Exclusive Strategic Partnership with International Biomedical Manufacturing Company, BPB Medica

PUR Biologics, a HippoFi biotech company, launches PURmarrow360 with BPB Medica, aiming to improve US patient safety and clinical outcomes in the 1.62M annual instrumented spinal fusions. IRVINE, CA /...

1 year ago - Accesswire

HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market

IRVINE, CA / ACCESSWIRE / July 25, 2023 / HippoFi, Inc. (OTC PINK:ORHB) - HippoFi, a healthcare technology and innovation firm focused on the development, acquisition, and sale of biologic products us...

1 year ago - Accesswire

HippoFi Anticipates a New Strategic Partnership as the Company Prepares to Launch PURmarrow 360, a Patented Stem Cell Harvesting Device

IRVINE, CA / ACCESSWIRE / July 25, 2023 / HippoFi, Inc. (OTC PINK:ORHB) a leading healthcare technology company and authority in spinal biologics, focused on the development and distribution of innova...

1 year ago - Accesswire

HippoFi's PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States

The nation's largest system includes 1,298 healthcare facilities IRVINE, CA / ACCESSWIRE / June 27, 2023 / HippoFi, Inc. (OTC PINK:ORHB) a leading healthcare technology company focused on the developm...

1 year ago - Accesswire

PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)

PURbonedough™ positioned to capture its share of the forecasted total spine market expected to grow from 13.3 billon in 2023 to 19 billion in 2030, a growth rate of 5.2% CAGR PURbonedough™ is PUR's mo...

2 years ago - Accesswire

PUR Biologics Expands Sales Network by 15%, Adding 32 New Distributors

IRVINE, CA / ACCESSWIRE / April 27, 2023 / HippoFi, Inc. (OTC PINK:ORHB), a leading healthcare innovator and technology company, is proud to announce the expansion of its biologics division, PUR Biolo...

2 years ago - Accesswire

US Patent Office Grants PUR Biologics' Breakthrough Patent for Activating Immune Cells

Patent thrusts PUR Biologics into the $200B immunotherapy market IRVINE, CA / ACCESSWIRE / April 21, 2023 / PUR Biologics, a wholly owned subsidiary of HippoFi (OTC PINK:ORHB) today announced the issu...

2 years ago - Accesswire

Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.

BALTIMORE, MD / ACCESSWIRE / April 20, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new r...

2 years ago - Accesswire

PUR Biologics Launches PURfiberXP(TM), a Best-in-Class Cortical Fiber Matrix for Bone Regeneration

IRVINE, CA / ACCESSWIRE / April 13, 2023 / PUR Biologics, a wholly owned subsidiary of HippoFi, Inc. (OTC PINK:ORHB), is pleased to announce the release of PURfiberXP™, a uniquely processed deminerali...

2 years ago - Accesswire

HippoFi Announces Its Return to a Pink Current Information Tier on the OTC Market

IRVINE, CA / ACCESSWIRE / April 11, 2023 / HippoFi, Inc. (OTC Pink:ORHB), a diversified company focused on the biotech and fintech markets, is pleased to announce that it has achieved Pink Current sta...

2 years ago - Accesswire

PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery

IRVINE, CA / ACCESSWIRE / April 6, 2023 / PUR Biologics, a subsidiary of HippoFi, Inc. (OTC PINK:ORHB), is proud to announce the launch of PURcoreTM, a unique moldable synthetic with an interconnected...

2 years ago - Accesswire

HippoFi Begins 2023 with Strong Sales of Advanced Biomaterials

Expanded sales force fuels market growth. IRVINE, CA / ACCESSWIRE / January 12, 2023 / HippoFi, Inc. (formerly ORHub), (OTC PINK:ORHB), a diversified company focused on the biotech and fintech markets...

2 years ago - Accesswire

HippoFi's Regenerative Therapeutics Division, Launches PURbridge(TM) for Spine Surgery

PURbridge ™ , an advanced synthetic and new form of bioactive glass, is positioned to significantly increase the Company's revenue throughout 2023 IRVINE, CA / ACCESSWIRE / November 23, 2022 / HippoFi...

2 years ago - Accesswire

HippoFi Signs Strategic Partnership Agreement with Precision Spine, Inc.

HippoFi accesses Precision Spine's major sales channels to speed its sales strategy & quickly drive revenue IRVINE, CA / ACCESSWIRE / October 5, 2022 / HippoFi, Inc. - formerly ORHub® (OTC PINK:ORHB) ...

2 years ago - Accesswire

ORHub Adopts New Name to Reflect Its Fintech Future - "HippoFi"

Born from ORHub®, HippoFiTM represents the company's fintech focus with commitment to the ‘Hippocratic oath' and patient clinical improvements. IRVINE, CA / ACCESSWIRE / August 24, 2022 / ORHub, Inc. ...

2 years ago - Accesswire

ORHub's PUR Biologics to Launch PUR Pillars

PUR PillarsTM were designed specifically for spine surgery, with a patient's post-surgical outcomes in mind. IRVINE, CA / ACCESSWIRE / July 28, 2022 / ORHub, Inc. (OTC Pink:ORHB) plans to launch its n...

2 years ago - Accesswire